ebola
viru
ebov
outbreak
result
confirm
case
across
three
contin
overal
mortal
rate
http
unlik
previou
outbreak
lack
prepared
west
africa
local
custom
facilit
transmiss
gener
poor
healthcar
infrastructur
key
unpreced
size
outbreak
intern
emerg
respons
therefor
necessari
arrest
rapidli
becam
global
health
secur
threat
thu
peak
transmiss
august
world
health
organ
declar
outbreak
public
health
emerg
intern
concern
pheic
http
quickli
becam
clear
success
contain
outbreak
would
pivot
three
action
reliabl
diagnosi
suspectedprob
case
ie
symptomat
individu
quick
isol
patient
confirm
infect
ebov
effect
contact
unfortun
symptomat
suspect
case
difficult
differenti
diagnos
caus
agent
hemorrhag
fever
symptom
gener
nonspecif
common
endem
high
incid
infect
malaria
yellow
fever
lassa
fever
furthermor
epidemiolog
inform
avail
margin
contribut
patient
triag
increas
ebov
diseas
risk
potenti
suspect
probabl
thu
becam
essenti
obtain
explicit
clinic
diagnost
grade
evid
activ
ebov
infect
quickli
possibl
patient
present
nucleic
acid
amplif
test
naat
use
thermal
cycl
fluoresc
probe
real
time
quantit
revers
transcript
polymeras
chain
reaction
rtqpcr
quickli
recogn
reliabl
clinic
diagnost
solut
symptomat
ebov
thu
studi
previou
data
emerg
west
reaffirm
patient
would
present
triag
symptom
becam
intens
correspond
high
viraemia
level
rang
genom
equival
per
ml
ge
per
ml
whole
blood
importantli
rtqpcr
intern
adopt
vitro
diagnost
ivd
technolog
consid
robust
sensit
highli
specif
unlik
territori
usa
food
drug
administr
fda
present
regul
stringent
ivd
thermal
cycler
instrument
associ
ivd
assay
kit
extens
clinic
trial
issu
market
author
furthermor
diagnost
servic
base
naat
provid
fdaregul
laboratori
servic
also
cover
infecti
diseas
agent
diagnost
includ
multitud
rna
regulatori
framework
appli
whether
diagnost
test
avail
independ
market
ivd
kit
assay
develop
inhous
regul
laboratori
use
regul
reagent
measur
enhanc
diagnost
servic
reliabl
requir
import
context
highli
infecti
diseas
hazard
group
pathogen
implement
naat
diagnost
ebov
diseas
spearhead
august
fda
emerg
use
author
eua
assay
use
famlabel
fluoresc
probe
rtqpcr
undertaken
one
sever
fdaapprov
thermal
cycler
http
molecular
test
involv
quantit
detect
two
rna
substrat
ebov
glycoprotein
gp
gene
encod
neg
rna
genom
ebov
human
ribonucleas
p
rp
transcript
found
high
level
human
biofluid
sampl
endogenousprocess
date
socal
trombley
remain
gold
standard
diagnost
use
public
health
agenc
worldwid
report
sensit
specif
semiquantit
ebov
diagnosi
viraem
ie
symptomat
thu
trombley
assay
featur
plaqu
form
unit
per
reaction
pfu
per
reaction
lower
limit
detect
llod
across
loglinear
dynam
rang
ldr
analyt
specif
human
rna
pathogen
http
note
qualif
perform
data
assay
pertain
reaction
substrat
ebov
rna
genom
rather
amount
live
viru
sampl
relat
use
infecti
viru
quantif
method
classic
virolog
pfu
quantif
assay
medic
valuabl
inform
risk
infectiontransmiss
rather
biochem
relev
assay
substrat
concentr
report
naat
yet
studi
vitro
produc
macaqu
infect
indic
viral
genom
might
higher
infecti
virion
given
sampl
evidenc
across
mani
hazard
group
virus
associ
extent
viru
passag
clinic
data
remain
limit
given
prefer
immedi
viru
inactiv
health
safeti
reason
unfortun
entir
trombley
procedur
slow
laboratorybas
consider
safeti
implic
thu
venou
blood
biolog
sampl
choic
larg
volum
need
ml
increas
risk
uncontrol
bleed
patient
exhibit
hemorrhag
symptom
sampl
also
present
risk
infect
healthcar
staff
collect
diagnost
laboratori
personnel
analyz
make
extens
safeti
train
essenti
reduc
transmiss
notwithstand
safeti
concern
trombley
assay
procedur
necessit
consider
technic
expertis
involv
multipl
manual
step
oper
expens
laboratori
infrastructur
mainspow
instrument
use
expens
consum
store
constantli
appropri
equip
facil
scant
west
africa
technolog
suit
laboratoryfre
field
deploy
rural
region
need
addit
cost
per
exceed
tenfold
annual
per
capita
healthcar
expenditur
moreov
timetoresult
best
hour
sampl
receipt
restrict
throughput
capac
present
addit
infect
risk
ebovfre
patient
await
result
whilst
triag
overal
peak
transmiss
assay
complex
cost
lack
speed
molecular
diagnosi
hamper
effort
stave
transmiss
address
challeng
mani
industri
academ
group
respond
call
solut
line
assur
relev
resourc
limit
set
thu
ideal
diagnost
test
afford
sensit
specif
userfriendli
robust
rapid
equipmentfre
deliver
need
ie
usabl
field
minim
requir
addit
resourc
ideal
would
also
involv
minim
biofluid
volum
microlit
drop
blood
analys
situ
digit
venipunctur
dissimilar
overthecount
pointofne
glucomet
date
clinic
advanc
closetopati
naat
ivd
still
requir
power
instrument
fulli
equip
laboratori
set
fix
mobil
train
associ
multipl
handl
step
start
ml
venou
blood
consum
still
far
costli
countri
affect
tropic
report
effort
address
need
quantit
rapid
reliabl
molecular
diagnosi
ebov
diseas
symptomat
patient
arriv
triag
month
emerg
call
research
health
humanitarian
crisi
program
enhanc
learn
research
humanitarian
assist
elrha
organ
take
account
report
quantit
pcr
qpcr
possibl
reaction
contain
present
evid
extend
rtqpcr
retain
quantit
diagnost
valu
without
need
substanti
formulationenzym
modif
provid
far
dye
use
overcom
fluorogen
inhibit
effect
blood
minim
impact
sensit
remain
clinic
accept
evalu
util
control
freez
thaw
cycl
disrupt
virion
structur
releas
viral
genom
directli
blood
sampl
energi
engineeringeffici
mean
elimin
manual
autom
rna
extract
purif
present
develop
instrument
comput
approach
compat
parallel
detect
multipl
far
dye
engin
field
deploy
point
need
laboratori
infrastructurefre
manner
minim
endus
train
requir
final
determin
perform
approach
detect
quantifi
ebov
gold
standard
laboratorybas
trombley
assay
within
context
screen
symptomat
patient
triag
set
given
emerg
evid
trombley
gp
assay
perform
better
number
rtqpcr
assay
focu
effort
adopt
trombley
assay
ebov
gp
np
gene
work
moreov
overcom
limit
biosafeti
level
facil
staff
avail
due
increas
screen
servic
demand
use
surrog
ebov
templat
reason
chemic
synthes
rna
templat
blood
nucleas
rapidli
degrad
biomateri
ambient
could
prove
problemat
minim
assay
formul
hand
de
novo
construct
vitro
produc
noninfecti
andor
replicationdefici
ebov
approach
common
mani
wellstudi
speci
mammalian
virus
activ
discourag
outsid
high
contain
reason
health
safeti
biosecur
thu
elect
use
commerci
avail
recombin
coliphag
primari
surrog
templat
despit
robust
virion
compar
easili
fragment
natur
filoviru
pseudotyp
lentiviru
pv
base
hiv
manufactur
inhous
fallback
templat
see
esi
fig
benchmark
trombley
assay
perform
standard
perform
platebas
kit
standard
oper
procedur
sop
real
time
thermal
thu
use
healthi
volunt
blood
freshli
collect
superfici
venipunctur
spike
final
concentr
ge
per
ml
blood
viral
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
manchest
uk
purifi
extract
serial
dilut
nucleasefre
water
volum
assay
triplic
result
demonstr
independ
amplif
effici
gp
np
assay
respect
despit
use
templat
result
distinct
curv
fit
determin
akaik
inform
criteria
test
fig
high
concentr
howev
allow
us
demonstr
linear
dynam
rang
ldr
assay
log
higher
report
moreov
genom
equival
per
reaction
ge
per
reaction
lower
limit
detect
llod
low
variabl
technic
replic
demonstr
confid
band
across
dilut
seri
cv
gp
np
set
perform
standard
forward
work
furthermor
gener
pv
construct
contain
trombley
assay
target
sequenc
correspond
ebov
yambukaecran
refer
genom
ebov
guinea
makona
refer
genom
confirm
singl
nucleotid
polymorph
identifi
within
west
african
outbreak
limit
impact
diagnost
assay
reliabl
see
esi
fig
tabl
previou
indic
pcr
contain
whole
blood
may
proceed
context
enabl
mutat
taq
dna
polymeras
omnitaq
mutant
least
one
commerci
avail
researchgrad
polymeras
supplement
reaction
howev
implement
reliabl
concern
independ
importantli
qpcr
sybr
green
nucleic
acid
stain
nm
emiss
peak
achiev
omnitaq
overcom
inhibitori
effect
blood
fluorogen
dosedepend
eg
use
higher
concentr
dye
reaction
spike
vv
blood
notabl
work
involv
blood
plasma
treat
anticoagul
known
pcr
inhibitor
sampl
five
time
use
green
dyelabel
probe
cal
fluor
nm
later
shown
group
requir
complex
pcr
enhanc
cocktail
achiev
detect
littl
genom
equival
per
microlit
ge
per
dna
templat
omnitaq
polymeras
presenc
blood
although
author
demonstr
cocktail
could
use
polymeras
endpoint
pcr
assay
discuss
use
rtqpcr
encourag
report
work
parallel
construct
pv
standard
investig
whether
blood
compat
pcr
could
extend
rna
templat
rtpcr
use
similar
wellcharacter
howev
line
project
applic
analyz
patient
blood
immedi
upon
collect
dispens
anticoagul
blood
storag
altogeth
instead
spike
fresh
human
blood
directli
reaction
obtain
digit
venipunctur
ad
hoc
thu
assembl
onestep
rtqpcr
reaction
commerci
avail
taq
polymeras
flex
promega
inc
bloodtoler
omnitaq
dna
polymeras
technolog
inc
use
manufactur
mastermix
respect
u
per
reaction
moloney
murin
leukemia
viru
revers
transcriptas
promega
importantli
although
mastermix
formul
remain
proprietari
supplier
confirm
neither
formul
featur
addit
overcom
pcr
inhibitor
work
wet
ice
reaction
spike
copi
escherichia
coli
phage
rna
famlabel
probe
nm
emiss
peak
increas
concentr
fresh
blood
fig
surpris
result
indic
rtpcr
success
proceed
presenc
blood
obviou
differ
hotstart
wild
type
taq
polymeras
fig
bloodadapt
omnitaq
mutant
fig
howev
case
blood
inhibit
fluorogen
signal
probe
concentrationdepend
manner
determin
whether
limit
use
fluoresc
label
probe
detect
chemistri
evalu
qpcr
output
omnitaq
copi
lambda
phage
dna
higher
sybr
green
concentr
vv
blood
line
stainblood
ratio
indic
kermekchiev
et
al
famlabel
probe
reaction
format
also
exhibit
blood
concentrationdepend
inhibit
fluorogen
signal
fig
taken
togeth
result
suggest
qpcr
rtqpcr
might
achiev
presenc
blood
despit
inhibitori
effect
wild
type
dna
polymeras
minim
mastermix
formul
provid
anticoagul
use
blood
sampl
inhibitori
effect
blood
dye
fluorogen
could
overcom
given
spectral
properti
blood
better
signaltonois
ratio
far
dye
optic
platform
confoc
microscopi
vivo
hypothes
far
redinfrar
fluorophor
might
resolv
fluorogen
inhibit
effect
blood
examin
hypothesi
emiss
spectra
gamut
commerci
avail
far
nucleic
acid
stain
famili
fluoresc
dye
quasar
quasar
assess
presenc
absenc
fresh
human
blood
fig
use
ocean
optic
maya
lsl
fluorimet
also
took
opportun
experi
evalu
varieti
light
sourc
light
emit
diod
luxeon
phillip
dragon
osram
filter
white
light
sourc
laser
diod
studi
use
laser
diod
sourc
provid
power
output
advantag
parallel
sever
reduc
engin
problem
optic
fiber
coupl
structur
stabil
dispens
wavelength
filter
requir
laser
discret
wavelength
light
sourc
thu
use
sourc
provid
excit
power
vessel
temperatur
stabil
stabl
power
wavelength
power
led
test
studi
also
suggest
emiss
peak
far
red
dna
stain
consist
affect
exhibit
minim
inhibit
eg
other
result
signal
increas
probabl
account
differenti
cell
permeabl
individu
bind
properti
stain
extracellularintracellular
dna
rna
fig
thu
whilst
ref
ref
cellperm
dna
stain
use
leukocyt
label
flow
cytometri
ref
appear
sensit
apoptot
cell
howev
select
dna
rna
remain
unclear
moreov
ref
ref
effect
enter
erythrocyt
select
detect
plasmodium
falciparum
infect
ref
select
stain
nucleat
erythroid
precursor
cell
suggest
might
select
dna
rna
whole
blood
assay
format
howev
show
compar
level
peak
signal
loss
exhibit
substanti
increas
peak
signal
level
follow
peak
signal
increas
report
result
therefor
indic
might
direct
util
substitut
sybr
green
whole
blood
qpcr
rtqpcr
especi
sinc
previous
demonstr
impact
pcr
stark
contrast
nucleic
acid
stain
probecompat
quasar
quasar
dye
consist
exhibit
signal
inhibit
fig
howev
three
allow
db
db
db
signaltonois
ratio
correspond
emiss
peak
fig
respect
rel
background
blood
emiss
spectra
fig
taken
togeth
result
indic
fluorogen
inhibit
effect
blood
might
restrict
green
dye
perhap
even
yelloworang
dye
make
far
red
fluorophor
gener
appropri
substitut
qpcr
rtqpcr
proceed
investig
procur
assay
gp
probe
conjug
array
far
dyequench
combin
presenc
vv
fresh
human
blood
fig
use
custom
optic
array
confirm
adequ
detect
signal
emiss
dyequench
combin
although
data
suggest
quencherspecif
interact
biolog
matrix
similar
report
involv
assay
see
signal
nonetheless
detect
dye
triag
dyequench
pair
base
manufactur
cost
probe
yieldpurif
signal
strength
arriv
quasar
optim
substitut
chemistri
particularli
sinc
stabil
issu
also
experienc
probe
batch
thu
proceed
examin
whether
use
fluorophorequench
combin
trombley
gp
assay
henceforth
refer
trombley
gp
assay
tabl
would
affect
rtqpcr
reaction
perform
use
rna
extract
fig
analyt
llod
gereact
log
ldr
cv
determin
gp
assay
reaction
effici
probabl
singl
curv
fit
famlabel
gp
assay
fig
use
akaik
inform
criterion
test
importantli
find
reaffirm
extend
analysi
ge
per
ml
llod
cv
effici
probabl
singl
curv
fit
fig
extern
surrog
standard
ebov
ge
per
ml
llod
cv
reaction
effici
probabl
singl
curv
fit
fig
togeth
result
indic
substitut
green
probe
chemistri
blood
compat
far
dyequench
pair
may
facilit
rapid
transit
prevalid
probebas
assay
whole
bloodcompat
rtqpcr
individu
assay
perform
notwithstand
clinic
diagnost
reliabl
pivot
elimin
possibl
fals
positiveneg
result
platebas
naat
assay
minim
risk
perform
diagnost
reaction
parallel
sampl
control
reaction
separ
posit
neg
control
reaction
serv
process
control
ensur
compar
level
diagnost
reliabl
point
care
system
requir
either
multiplex
analysi
appropri
control
within
singl
reaction
chamber
microfluidicmultipl
reaction
chamber
detect
distinct
templat
reason
singl
reaction
chamber
solut
would
maintain
minim
consum
cost
assuredcompat
point
need
system
dna
intercal
stain
sybr
green
use
multiplex
assay
approach
high
resolut
melt
curv
analysi
report
individu
amplicon
hand
implement
methodolog
requir
either
substanti
expert
endus
signific
algorithm
andor
high
complex
costli
moreov
immedi
relev
ebov
gp
rp
assay
kit
involv
probebas
detect
case
exist
assay
readili
multiplex
competit
pcr
inhibit
experiment
evidenc
fluorophor
spectral
distinct
emiss
peak
instrument
perspect
probe
multiplex
requir
either
multipl
detector
equip
detect
rang
filter
singl
detector
mount
move
filter
wheel
equip
relev
wavelength
filter
solut
howev
bear
manufactur
cost
instrument
reliabl
implic
due
requir
multipl
andor
move
part
illsuit
field
deploy
resourcelimit
countri
make
singl
detector
approach
lack
filter
requir
propos
herein
valuabl
solut
although
model
effort
confirm
spectral
unmix
allow
concomit
use
quasar
quasar
duplex
triplex
see
multiplex
gp
np
rp
assay
result
loss
sensit
therefor
focus
demonstr
robust
proof
principl
platform
singleplex
format
opt
defin
key
multiplex
paramet
comput
model
base
highli
kinet
spectral
method
principl
see
esi
fig
model
result
justifi
use
spectrophotometri
data
acquisit
bloodcompat
point
care
instrument
would
support
dna
stain
high
resolut
melt
analysi
assay
quantit
multiplex
probebas
assay
consequ
final
excitationemiss
detect
array
determin
involv
ocean
optic
maya
lsl
tune
detect
light
rang
nm
offer
capac
parallel
independ
sampl
test
instrument
also
configur
offer
independ
sampl
well
necessit
custom
octofurc
fiber
fig
share
spectrophotomet
end
consist
na
low
oh
core
fiber
termin
singl
key
sma
connector
attach
spectrophotomet
order
allow
random
access
facilit
use
singl
share
spectrophotomet
well
illumin
individu
spectra
observ
could
attribut
specif
sampl
emissioncollect
leg
fiber
termin
one
end
individu
nm
laser
diod
per
reaction
posit
locat
reaction
vessel
barrel
len
focus
collim
excit
emiss
fig
c
laser
diod
built
hous
sma
connector
nm
bandpass
built
remov
excit
outsid
nm
laser
line
thorlab
nm
longpass
filter
built
entranc
maya
lsl
filter
unwant
laser
light
result
emiss
spectra
confirm
implement
emissiondetect
chemistri
optic
array
would
perform
expect
first
built
singl
well
peltierbas
thermal
cycl
test
rig
fig
around
spectrophotometr
test
array
also
moldmanufactur
custom
design
reaction
consum
mold
thermal
conduct
w
carbon
load
polypropylen
compound
consist
carbon
lati
spa
vedano
olona
itali
easi
handl
puck
correspond
clear
optic
lid
fig
reduc
thermal
energi
requir
freez
rapid
thermal
cycl
vessel
optic
clear
cap
topdown
excitationemiss
measur
use
previous
describ
reflect
probe
next
proceed
test
amplif
effici
bloodcompat
trombley
assay
quasar
gp
probe
rna
extract
across
diagnost
laboratori
standard
instrument
consum
vs
test
rig
fig
use
onset
amplif
threshold
cycl
ct
call
well
curv
smoothen
develop
live
ct
call
protocol
base
real
time
data
process
use
raw
fluoresc
valu
obtain
run
data
first
baselin
averag
fluoresc
valu
observ
cycl
prior
fluoresc
rise
new
valu
screen
determin
highest
fluoresc
observ
channel
rel
fluoresc
valu
well
determin
divid
cycl
observ
fluoresc
valu
maximum
valu
graph
cycl
rel
fluoresc
scale
plot
cycl
number
increas
fluoresc
baselin
taken
ct
result
indic
compar
reaction
rate
ct
valu
across
two
platform
ct
respect
fig
despit
markedli
differ
reaction
volum
consum
thermal
properti
ramp
rate
instrument
optic
signal
process
algorithm
support
use
real
time
thermal
cycl
system
phase
transit
ice
crystal
format
freez
releas
intracellular
content
disrupt
cytosol
nuclear
membran
protein
denatur
high
temperatur
also
disrupt
ribonucleoprotein
complex
therebi
releas
nucleic
acid
analyt
assay
use
togeth
propos
two
process
might
enabl
access
bacteri
dna
templat
real
time
pcr
singl
chamber
system
without
need
biolog
sampl
preprocess
hypothes
process
would
also
stress
viral
particl
structur
adequ
allow
rtpcr
detect
viral
rna
singl
reaction
chamber
sought
test
hypothesi
coliphag
virion
armor
reason
proof
principl
robust
templat
would
like
extend
lipidenvelop
virus
fragil
manual
preliminari
experi
suggest
cycl
freez
denatur
optim
releas
rna
virion
high
level
rnase
activ
biofluid
ambient
temperatur
ref
avoid
see
esi
fig
therefor
decid
carri
experi
use
autom
thermal
cycl
capabl
reach
replac
denatur
simpl
thaw
would
also
allow
us
examin
whether
denatur
inde
essenti
releas
viral
rna
genom
virion
access
revers
transcriptas
thu
assembl
peltier
thermal
cycl
rig
around
custom
bloodcompat
spectrophotometr
emissiondetect
array
use
earlier
experi
modifi
use
heat
remov
modul
hrm
fluid
cool
heatsink
wherebi
fluid
case
held
temperatur
intermedi
pcr
extens
temperatur
freez
point
enabl
rapid
cool
reli
high
level
thermal
isol
heatsink
sampl
peltier
reli
upon
drive
reaction
fluid
excess
hrm
henc
make
possibl
freez
higher
temperatur
environ
test
also
use
trombley
assay
ge
custommanufactur
ebov
armor
coliphag
construct
final
given
result
rtpcr
enzym
toler
blood
perform
test
abi
fast
viru
master
mix
use
diagnost
assay
devic
achiev
overal
sampletoansw
minut
ahead
addit
rtpcr
thermal
cycl
time
optim
beyond
standard
cycl
time
use
assay
result
reproduc
outcom
manual
studi
identifi
cycl
optim
viral
particl
disrupt
rang
fig
moreov
experi
confirm
denatur
necessari
access
viral
nucleic
acid
form
viral
particl
disrupt
even
highli
robust
coliphag
virion
therefor
proceed
next
examin
trombley
assay
toler
blood
progress
increas
blood
input
vv
reaction
contain
ge
per
reaction
fig
thu
bloodfre
reaction
return
ct
loss
signal
ct
observ
low
blood
concentr
howev
trend
revers
peak
vv
blood
signal
loss
ie
ct
crucial
small
signal
loss
affect
assay
lower
limit
quantif
lloq
fig
ge
success
discrimin
templat
vv
bloodcontain
reaction
two
posit
sampl
indistinguish
result
indic
although
quantif
lower
end
trombley
assay
could
compromis
presenc
blood
detect
could
still
reliabl
achiev
basi
pfu
per
ml
whole
blood
detect
limit
laboratorybas
trombley
reason
use
microlit
whole
blood
method
ie
pfu
per
reaction
volum
compat
digit
venipunctur
would
match
perform
laboratori
method
whilst
remain
limit
quantif
exhibit
experiment
thu
total
reaction
volum
method
final
contain
blood
sampl
vv
determin
whether
accur
sampl
scale
could
take
place
field
evalu
rang
ivdgrad
graduat
plastic
capillari
sampler
observ
standard
deviat
collect
pasteur
pipettelik
capillari
n
conduct
oper
wear
person
protect
equip
compar
use
frontlin
healthcar
worker
triag
center
achiev
assay
chemistri
detect
system
sampl
volum
predict
match
diagnost
reliabl
laboratorybas
trombley
assay
proceed
construct
prototyp
pointofcar
instrument
fig
importantli
design
use
triag
scenario
eg
emerg
respons
primari
care
center
vehicl
mobil
outbreak
respons
team
seek
quantit
rapidli
identifi
qurapid
ebov
diseas
symptomat
patient
either
main
power
car
altern
power
sourc
initi
design
lightweight
print
format
final
kg
tabletop
prototyp
sought
reduc
risk
unauthor
remov
triag
centr
ensur
robust
transport
eg
offroad
set
addit
tabletop
instrument
featur
random
access
assay
station
allow
independ
parallel
oper
touch
screen
interfac
compat
glove
sop
also
devis
esi
video
onlin
fig
line
simplic
necessari
minim
train
frontlin
staff
focus
patient
care
high
stress
environ
whilst
full
person
protect
equip
includ
consum
design
autom
buffer
dispens
secur
thermal
cycl
would
minim
risk
environment
contamin
oper
error
accident
sampl
releas
outbreak
end
time
novemb
limit
number
new
case
mean
deliv
evid
clinic
relev
live
ebov
restrict
either
store
sampl
culturederiv
ebov
test
simul
patient
sampl
previou
report
indic
store
blood
sampl
impact
effici
complet
motiv
us
seek
sampl
store
absenc
addit
known
impact
pcr
howev
anecdot
evid
indic
substanti
oper
variabl
sampl
storag
procedur
throughout
west
african
outbreak
therefor
minim
impact
variabl
inher
store
sampl
vs
minim
direct
sampl
analysi
process
elect
proceed
laboratori
test
rang
live
culturederiv
filovirus
hand
collect
fresh
human
blood
digit
venipunctur
prohibit
health
safeti
reason
result
fetal
bovin
serum
fb
obtain
without
use
anticoagul
preserv
use
surrog
biolog
matrix
human
blood
also
acknowledg
direct
volum
substitut
blood
serum
would
doubl
final
concentr
serum
compon
reaction
doubl
parallel
pcr
inhibitori
effect
thu
perform
bloodcompat
trombley
gp
assay
quasar
abi
fast
viru
master
mix
qurapid
prototyp
evalu
fast
gold
standard
sop
mastermix
famlabel
gp
assay
varieti
filovirus
tabl
undertak
assay
transfer
prequalif
standard
fig
infecti
culturepropag
filovirus
serial
dilut
test
result
concentr
qurapid
altern
serial
dilut
virus
extract
purifi
assay
accord
assay
sop
result
indic
trombleyqurapid
system
could
detect
littl
pfu
per
ml
whole
bloodequival
live
ebov
yambuka
ecran
fig
lloq
pfu
per
ml
whole
bloodequival
importantli
howev
perform
across
capsid
surrog
virus
ebov
yambukaecran
ebov
makona
guinea
consist
term
analyt
quantifi
rtqpcr
ie
genom
equival
rather
number
viabl
virion
fig
crucial
fals
posit
encount
across
templatefre
control
genet
relat
virus
confirm
analyt
specif
compromis
presenc
fb
fluorophor
migrat
far
red
spectra
furthermor
data
obtain
independ
experi
carri
across
seven
day
use
multipl
separ
viru
type
batch
nevertheless
despit
propens
pcr
technolog
manual
error
result
follow
loglinear
relationship
viru
genom
concentr
ct
call
probabl
singl
curv
fit
linear
regress
result
indic
assay
perform
rel
quantif
could
precalibr
use
coliphag
safeti
standard
inhibitori
effect
fb
blood
affect
assay
linear
basi
investig
extent
data
gener
two
platform
inde
compar
independ
calibr
dataset
standard
curv
gener
use
calcul
unknown
filoviru
stock
concentr
ge
per
ml
analysi
indic
qurapid
platform
return
data
compar
gold
standard
labbas
trombley
method
tabl
howev
also
highlight
use
manual
extractionpurif
might
sensit
noninfecti
viral
genom
analyt
stabilis
qurapid
whole
blood
assay
might
less
thu
number
viral
genom
viabl
virion
pfu
ratio
ebov
yambukaecran
higher
younger
ebov
guinea
makona
isol
irrespect
platform
use
consist
lower
qurapid
result
line
separ
suggest
viru
extens
passag
vitro
might
produc
fewer
infecti
virion
vs
newer
isol
therebi
increas
ratio
genom
infecti
particl
biofluid
socioeconom
valu
molecular
diagnost
contain
highli
infecti
diseas
convincingli
demonstr
west
concurr
centraleast
african
ebov
south
korean
middl
east
respiratori
syndrom
coronaviru
merscov
furthermor
histor
data
causal
link
intern
travel
mass
attend
event
pandem
therefor
capac
deploy
appropri
reliabl
costeffect
diagnost
capabl
intern
public
health
requir
yet
date
exist
true
point
need
solut
suitabl
mass
screen
support
effect
contain
intern
port
entri
outbreak
triag
center
etc
minim
econom
burden
transport
intern
trade
disrupt
inde
expect
singl
system
prove
univers
util
given
transmiss
symptomatolog
carrier
statu
may
differ
vastli
depend
biolog
pathogen
thu
best
detect
use
distinct
analyt
procedur
rather
flexibl
approach
need
adopt
center
respond
rapidli
implement
appropri
technolog
proportion
procedur
relev
key
factor
patient
present
diseas
dissemin
thu
whilst
mani
highli
infecti
viral
diseas
may
dissemin
asymptomat
carrier
ebov
transmiss
requir
viraemia
whose
level
correl
symptom
intens
inde
surviv
result
mani
effort
made
detect
presymptomat
level
ebov
sever
anecdot
report
variou
naat
detect
presymptomat
individu
cours
evalu
west
african
outbreak
present
howev
reliabl
evid
thereto
pertain
host
microrna
biomark
signatur
detect
naat
blood
howev
presymptomat
rel
low
infect
statu
classif
potenti
therefor
reliabl
contain
futur
ebov
outbreak
pivot
effect
detect
screen
symptomat
individu
crucial
ebov
posit
patient
typic
present
viraemia
level
well
excess
ge
per
ml
whole
blood
ie
order
magnitud
llod
trombley
rtqpcr
assay
demonstr
multipl
studi
west
well
histor
diagnost
solut
propos
ebov
infecti
diseas
advanc
minim
endus
input
technolog
includ
antibodi
later
flow
semiautom
latter
howev
remain
reliabl
robust
method
diagnos
ebov
viraem
antibodi
system
suit
exclus
screen
cadav
patient
exhibit
intens
yet
naat
use
diagnost
purpos
west
requir
mobil
laboratori
thu
benchtop
filmarray
cepheid
naat
receiv
andor
fda
eua
west
african
outbreak
instrument
requir
basic
laboratori
infrastructur
semiquantit
multiplexingcompat
eight
time
faster
manual
trombley
method
whilst
offer
fdaapprov
differenti
diagnosi
cost
per
test
assay
singl
agent
offer
medium
throughput
scalabl
devic
case
howev
sampl
process
still
requir
flexiblefilm
isol
contain
technic
expertis
pertain
manual
step
involv
knowhow
relat
data
interpret
nonetheless
togeth
solut
allow
index
case
causal
agent
identif
provid
capac
screen
albeit
still
laboratori
set
consider
cost
larg
due
microfluid
andor
pump
mechanis
mani
manual
procedur
possibl
thu
overal
test
compar
price
laboratorybas
trombley
assay
wherea
ebov
test
remain
twice
expens
annual
per
capita
healthcar
spend
west
africa
despit
charit
develop
fund
exwork
price
negoti
find
diagnost
behalf
substanti
reimburs
gate
foundat
importantli
recent
announc
portabl
omni
offer
singl
sampl
analysi
capac
albeit
improv
sampletodata
turnaround
hour
question
mass
screen
util
moreov
system
close
access
mean
public
health
author
independ
respond
emerg
threat
rapidli
transit
inhous
develop
assay
dissemin
use
platform
tellingli
trombley
assay
receiv
fda
eua
day
pheic
declar
wherea
cepheid
platform
requir
sever
month
addit
develop
elsewher
emerg
altern
naat
solut
focu
energi
effici
isotherm
amplif
well
agnost
de
novo
analyt
power
memori
sticksiz
sequenc
whilst
mani
success
evalu
resourcelimit
solut
still
requir
extens
costli
laboratori
infrastructur
sampl
even
onto
genom
close
requir
high
bandwidth
data
transfercomput
power
realiz
potenti
work
demonstr
control
low
temperatur
virus
structur
divers
coliphag
armor
ebov
releas
virion
genom
within
complex
biofluid
matrix
serum
fresh
blood
furthermor
evidenc
simpl
substitut
commonli
use
green
dna
stain
probe
dye
redfar
red
fluorophor
spectral
compat
blood
elimin
fluorogen
inhibit
rtqpcr
unlik
previou
report
involv
variou
format
stabil
hand
use
freshli
obtain
blood
eg
digit
venipunctur
appear
extens
entir
inhibit
pcr
importantli
combin
control
freezethaw
far
red
fluorophor
simpl
rtqpcr
enzym
formul
found
reliabl
enough
adequ
colinearli
detect
specif
genet
target
across
least
two
class
virus
assay
separ
day
knowledg
first
use
precalibr
standard
rtqpcrmediat
sampl
quantif
directli
whole
blood
across
wide
dynam
rang
minim
impact
sensit
impact
diagnost
specif
thu
pfu
per
ml
whole
blood
equival
detect
limit
trombley
assay
qurapid
platform
approxim
one
order
magnitud
higher
detect
limit
gold
standard
laboratorybas
test
first
glanc
might
appear
great
differ
novel
gold
standard
platform
howev
trombleyqurapid
llod
compar
independ
report
lloq
gold
standard
pfu
per
nonetheless
metric
relat
viral
genom
analyt
detect
assay
rather
perform
qualif
express
rel
concentr
viabl
infecti
viral
particl
imposs
quantifi
rtqpcr
howev
data
latest
independ
trombley
assay
perform
present
gepfu
ratio
make
direct
comparison
accept
across
studi
laboratori
platform
thu
context
ge
per
ml
greater
viraemia
level
exhibit
symptomat
ebov
result
evid
clinic
util
propos
approach
meet
demand
futur
ebov
outbreak
subject
complet
necessari
eua
qualif
studi
moreov
ebov
cach
cerebrospin
fluid
survivor
may
lead
also
briefli
examin
whether
method
compat
biofluid
thu
observ
effect
blood
contamin
trombleyqurapid
ct
call
spike
ge
reaction
contain
vv
human
cerebrospin
fluid
fig
approach
may
therefor
offer
util
beyond
symptomat
ebov
diagnosi
infecti
viral
diseas
viraemia
level
relev
detect
limit
methodolog
also
rapid
econom
detect
caus
mening
timetodiagnosi
daylong
classic
clinic
microbiolog
might
disadvantag
importantli
howev
unlik
mani
approach
perform
report
novel
platform
achiev
less
blood
volum
standard
ml
need
gold
standard
trombley
assay
studi
therefor
underway
explor
whether
larg
volum
accommod
higher
amount
patient
sampl
point
care
might
meet
even
exceed
sensit
sop
beyond
sensit
specif
line
assur
key
dissemin
use
novel
technolog
especi
resourc
limit
set
test
afford
present
diagnost
relev
reaction
format
dispos
trombley
assay
qurapid
cost
us
per
test
scale
subsidi
amount
relev
develop
nation
competit
emerg
dispos
isotherm
naat
reli
complex
fabric
thu
context
power
pointofne
solut
minut
cycl
freezethaw
process
implement
approach
add
addit
watt
energi
requir
per
test
nonetheless
addit
manag
smart
thermal
load
share
activ
station
oper
ad
hoc
therebi
reduc
overal
energi
requir
screen
use
moreov
overhead
effect
compens
lack
motor
expens
consum
instrument
part
could
otherwis
compromis
instrument
robust
extend
principl
overal
process
userfriendli
addit
minim
greatest
extent
possibl
manual
step
involv
conduct
rtqpcr
esi
video
without
recours
laboratori
infrastructur
introduct
manufactur
complex
thu
standard
oper
procedur
devis
involv
dispos
consum
preload
lyophil
reagent
autom
precalibr
solvent
dispens
elimin
need
refriger
although
abi
fast
rtqpcr
mastermix
test
live
ebov
amen
lyophilis
refrigerationfre
rtqpcr
mastermix
product
commerci
avail
research
diagnost
purpos
end
screen
identifi
proprietari
lyophilis
bloodcompat
formul
success
dri
test
part
work
formul
present
develop
match
wet
assay
perform
characterist
report
herein
essenti
requir
diagnost
technolog
particularli
hazard
group
pathogen
howev
safeti
take
form
oper
safeti
diagnost
reliabl
although
use
flexibl
film
isol
qurapid
instrument
would
subject
local
health
safeti
requir
orang
red
triag
zone
ivdmark
low
oper
risk
sheath
lancet
digit
venipunctur
readili
cheapli
avail
counter
eg
use
point
care
glucomet
hand
safe
handl
full
person
protect
equip
suitabl
hazard
group
pathogen
use
plastic
capillari
low
error
rate
trial
herein
also
elimin
risk
injuri
instrument
contamin
beyond
puck
consum
similarli
optic
lid
addit
secur
place
qurapid
thermal
cycl
weight
topdown
detector
magnet
held
place
thu
process
complet
consum
dispos
hazard
clinic
wast
instrument
wipe
inde
fumig
crucial
instrument
electron
optic
damag
failur
observ
fumig
exit
prototyp
qurapid
platform
contain
test
live
ebov
therefor
platform
retain
mobil
repeat
util
requir
pertin
rapid
respons
outbreak
scenario
hand
experiment
evid
requir
support
accur
detect
multiplex
rtqpcr
support
safe
call
process
diagnost
success
use
technolog
unfortun
hand
singleplex
trombley
assay
rp
control
assay
exhibit
competit
inhibit
lower
end
analyt
concentr
reason
alter
even
primer
probe
concentr
would
requir
requalif
assay
specif
decid
instead
confirm
util
approach
ebov
genom
detect
singleplex
mode
nevertheless
result
fluorimetr
data
use
examin
state
art
mathemat
deconvolut
approach
use
optic
platform
oper
spectral
rang
analysi
indic
separ
commerci
avail
probe
fluorophor
nm
rang
adequ
assay
spectrophotometr
signal
nois
ratio
fluorophor
might
direct
use
multiplex
fashion
thu
exampl
dye
trio
consist
quasar
quasar
could
enabl
migrat
establish
triplex
assay
far
red
bloodcompat
spectrum
signal
nois
ratio
quasar
context
blood
would
make
fluorophor
suitabl
detect
high
copi
number
control
encouragingli
spectral
data
obtain
throughout
studi
quasar
probe
line
predict
model
effort
regard
peak
ratiometri
thu
fluorigen
data
normal
clearli
exhibit
adequ
assay
window
reliabl
detect
emiss
peak
chang
deviat
ratiometr
profil
detect
quasar
rel
dye
emiss
peak
effort
thu
underway
implement
autom
ct
call
multiplex
mode
well
viral
genom
quantif
reagent
precalibr
base
observ
across
two
distinct
ebov
strain
test
overal
whether
substitut
probebas
detect
chemistri
dna
stain
highresolut
melt
enabl
cost
reduct
futur
larg
depend
rel
diagnost
reliabl
comput
energi
requir
two
approach
use
presenc
blood
vs
alreadi
avail
highli
reliabl
probe
assay
context
respons
merscov
south
korean
outbreak
timetotransf
establish
probe
chemistri
assay
onto
qurapid
platform
far
red
bloodcompat
chemistri
calcul
six
eight
week
rate
limit
step
surrog
templat
product
b
reagent
synthesi
thu
stockpil
notwithstand
estim
laboratori
robust
reagent
suppli
chain
could
independ
deliv
mass
screen
mass
productionreadi
assay
within
fortnight
limit
impact
establish
assay
migrat
bloodcompat
chemistri
observ
herein
coupl
readili
avail
high
confid
comput
assay
design
capabl
parallel
screen
capac
even
suggest
util
pathogen
genom
drift
enabl
rapid
respons
newli
identifi
pathogen
focus
trombley
primer
probe
set
ebov
gp
np
consid
human
rp
assay
escherichia
coli
phagespecif
assay
fluoresc
probe
intercalatorbas
blood
toler
studi
sybr
green
thermo
fischer
scientif
warrington
uk
primer
tabl
synthes
integr
dna
technolog
leuven
belgium
probe
purchas
thermo
fisher
scientif
fam
idtdna
fam
leuven
belgium
lgc
biosearch
technolog
ltd
quasar
belfast
uk
comput
pcr
perform
analysi
carri
use
dna
softwar
ann
arbor
mi
usa
fluorophor
purchas
thermo
fisher
scientif
instrument
calibr
ddb
fluorogen
ltd
viridian
red
lgc
biosearch
ltd
atto
dye
determin
toler
commerci
avail
rt
pcr
enzym
blood
onestep
reaction
master
mix
assembl
wet
ice
use
hot
start
polymeras
promega
southampton
uk
hot
start
colorless
master
mix
promega
supplement
unit
moloney
murin
leukemia
viru
revers
transcriptas
promega
primer
probesdy
concentr
previous
duplic
aliquot
dispens
supplement
blood
nucleasefre
water
promega
achiev
final
blood
concentr
indic
templat
ad
last
aliquot
achiev
final
reaction
volum
ahead
commenc
thermal
cycl
illumina
run
softwar
illumina
inc
san
diego
ca
usa
enabl
acceler
develop
biosafeti
level
use
hepat
c
hcv
armor
rna
asuragen
inc
austin
tx
usa
manual
phase
disrupt
studi
coliphag
virion
model
three
ebov
surrog
tabl
custom
armor
rna
ref
ge
per
ml
stock
concentr
quantifi
synthet
rna
templat
rtqpcr
two
inhous
produc
pseudotyp
lentivirus
surrog
featur
rna
genom
engin
contain
concaten
target
site
trombley
gp
np
assay
encod
yambukaecran
ebov
guinea
makona
gener
recombin
lentivirus
assay
target
flank
bamhi
noti
geneart
plasmid
thermo
fisher
scientif
transfer
plasmid
pdualegfp
gift
david
escor
univers
colleg
london
lentivirus
assembl
cell
grown
vv
fetal
bovin
serum
fb
supplement
dulbecco
modifi
eagl
medium
dmem
thermo
fisher
scientif
vv
use
secondgener
method
involv
mg
per
ml
polyethylenimin
sigma
aldrich
dorset
uk
cotransfect
gift
didier
trono
addgen
plasmid
carri
envelop
protein
vesicular
stomat
viru
encod
lentivir
core
plasmid
ratio
respect
supernat
replac
ml
fresh
media
hour
filterharvest
hour
storag
cell
fed
fresh
media
ml
lentiviru
filterharvest
hour
pool
concentr
g
hour
resuspend
ml
dmem
recentrifug
ml
wv
sucros
cushion
resuspend
ml
dmem
storag
yield
viral
particl
per
ml
vp
per
ml
genom
equival
per
ml
ge
per
ml
deriv
use
nanosight
malvern
instrument
malvern
uk
dilut
vv
fbssupplement
dmem
interpol
standard
curv
rna
extract
trombley
assay
construct
respect
rna
extract
obtain
use
qiaamp
viral
rna
mini
kit
qiagen
manchest
uk
accord
manufactur
instruct
assum
extract
effici
fresh
human
blood
asept
obtain
digit
venupuctur
healthi
adult
male
volunt
liteii
lancet
vwr
lutterworth
uk
approv
univers
westminst
research
ethic
committe
applic
nov
inform
consent
obtain
experiment
human
subject
cerebrospin
fluid
csf
kindli
provid
prof
solomon
univers
liverpool
patient
sampl
simul
use
fb
thermo
fisher
scientif
platebas
rtqpcr
assay
carri
thermo
fisher
scientif
accord
manufactur
sop
specifi
assay
briefli
extractionpurif
use
qiaamp
viral
rna
mini
kit
eluent
rna
serial
dilut
use
nucleasefre
water
qiagen
manchest
uk
trombley
assay
onestep
carri
sampl
abi
fast
viru
master
mix
thermo
fisher
scientif
final
reaction
volum
faction
threshold
cycl
ct
valu
obtain
use
abi
softwar
implement
onset
amplif
ct
call
perform
metric
deriv
technic
triplic
use
electron
pipett
data
repres
mean
confid
band
ldr
test
triplic
averag
standard
deviat
unless
otherwis
specifi
preprototyp
work
phase
transit
carri
use
manual
acetonedri
ice
bath
dri
block
cycl
standard
ml
pcr
tube
thermo
fisher
scientif
sampl
temperatur
measur
separ
tube
load
equal
volum
mock
sampl
alcohol
thermomet
monitor
ramp
hold
rate
instrument
softwar
develop
novel
qurapid
fig
thermal
cycler
involv
raspberri
pi
raspberri
pi
foundat
cambridg
uk
control
singlewel
prototyp
fig
customfabr
thermal
control
print
circuit
board
evalu
complet
luxeon
rebel
rang
light
emit
diod
lumil
amsterdam
holland
filter
white
light
sourc
laser
diod
osram
regensburg
germani
perform
test
carri
two
separ
instrument
three
separ
laboratori
univers
westminst
biogen
ltd
public
health
england
fluorophor
probe
dyequench
compat
blood
assess
duplic
ad
blood
directli
reaction
master
mix
final
volum
result
express
absolut
fluoresc
summar
differ
fluoresc
posit
neg
presenc
absenc
blood
backgroundsubtract
emiss
peak
defin
wavelength
highest
emiss
intens
dye
peak
emiss
intens
defin
averag
intens
nm
specif
wavelength
valu
total
signal
nois
ratio
calcul
blood
sampl
read
within
wavelength
region
defin
dye
measur
presenc
blood
threshold
valu
calcul
standard
deviat
emiss
peak
averag
intens
dyefre
blood
background
sampl
data
process
carri
microsoft
excel
microsoft
read
uk
graphic
represent
perform
microsoft
excel
graphpad
prizm
san
diego
ca
usa
enduserdirect
sop
video
onlin
base
final
reaction
volum
fresh
blood
sampl
vv
final
blood
concentr
reaction
summar
fig
infecti
virus
evalu
studi
tabl
specif
stock
produc
porton
laboratori
public
health
england
live
virus
quantifi
titrat
obtain
tissu
cultur
infecti
dose
cell
european
collect
cell
cultur
uk
titer
convert
pfu
per
ml
multipli
valu
assum
poisson
live
viru
manipul
qurapid
analys
perform
across
separ
day
includ
instrument
precalibr
run
live
virus
serial
dilut
fb
minim
essenti
medium
plu
mem
thermo
fisher
scientif
use
templat
qurapidmigr
trombley
gp
assay
trombley
assay
reaction
compris
rtqpcr
mastermix
fast
viru
master
mix
thermo
fisher
scientif
primer
probe
tabl
fbsdilut
viru
fb
memdilut
viru
directli
ad
assay
perform
express
ct
call
titrationderiv
infecti
viru
concentr
pfu
per
ml
genom
content
ge
per
ml
base
precalibr
independ
sampl
across
two
viru
dilut
seri
per
dilut
chemic
inactiv
accord
phe
hazard
group
inactiv
method
sampl
tube
disinfect
deterg
accord
phe
disinfect
polici
safe
work
materi
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
quantifi
rna
extract
standard
curv
use
appli
biosystem
fast
thermo
fisher
scientif
primer
probe
set
specif
filovirus
ebov
use
specif
test
tabl
stock
virion
concentr
ge
per
ml
quantifi
titrat
rang
averag
calcul
per
analyt
platform
linear
regress
analys
defin
assay
ldr
conduct
graphpad
prizm
mean
technic
triplic
confid
band
graphic
repres
across
titrat
rang
test
probabl
singl
curv
fit
independ
assay
assay
templat
determin
akaik
inform
criteria
test
conduct
blind
sampl
data
use
graphpad
prizm
diagnost
paramet
determin
accord
armbrust
conceiv
research
select
n
e
assay
use
herein
establish
assist
n
k
r
r
technolog
specif
standard
oper
procedur
requir
minimum
accept
perform
criteria
system
progress
e
e
w
plan
oversaw
execut
work
present
herein
k
r
r
overse
work
l
consult
euagrad
assay
develop
requir
k
e
k
r
r
design
recombin
virion
assay
target
site
e
k
evalu
manual
comput
biochem
impact
assay
templat
genet
drift
assay
perform
k
undertook
assist
l
u
assay
transfer
modif
valid
work
k
e
b
e
w
construct
recombin
hiv
pseudotyp
virion
standard
c
c
l
perform
rtqpcr
blood
inhibit
bloodcompat
lyophil
assay
develop
studi
guidanc
l
e
n
n
e
propos
use
red
dye
bloodcompat
rtqpcr
e
k
establish
optim
condit
bloodcompat
singl
multiplex
rtqpcr
conduct
multiplex
model
n
n
oversaw
implement
e
instrumentconsum
engin
softwar
standard
oper
procedur
specif
set
advis
incountri
requir
k
r
n
l
e
j
b
c
b
k
r
r
perform
procedur
describ
herein
k
k
r
r
e
prepar
manuscript
equal
support
contribut
author
author
declar
compet
financi
interest
